Seattle Genetics reported $200.66M in Stock for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Stock Change
Bayer BAYN:GR € 11314M 670M
Daiichi Sankyo 4568:JP Y 211606M 1616M
Eisai 4523:JP Y 92511M 2468M
Nektar Therapeutics NKTR:US $ 15.8M 0.47M
Novartis NOVN:VX SF 6666M 219M
Teva Pharmaceutical TEVA:IT 3.82B 349M